John A Hurvitz

John Hurvitz co-chairs Covington’s Life Sciences Industry Group and Technology Transactions Group and leads its Life Sciences Transactions practice. He is a trusted advisor to both established and emerging life sciences companies, providing not only transactional counsel but also strategic advice with respect to business development, asset management, performance enhancement, dispute resolution under existing collaborations, industry best practices and other benchmarking advice. He has extensive experience structuring, negotiating, and documenting sophisticated, multidisciplinary, cross-border collaborations and M&A transactions. His clients and deal experience extend throughout the United States, Europe and Asia as well to emerging markets and include all segments of the industry—pharma, biotech, medtech, diagnostics, animal health, vaccines and health services.

Yale Law School, JD, 1991; Salomon Brothers, Mergers, Acquisitions and Divestitures Group, Financial Analyst; Georgetown University Law Center, Food and Drug Law, Adjunct Professor.